Holen Sie sich die Stockscreener-App
116.61
3.72%
4.115
Schlusskurs vom Vortag:
$112.49
Offen:
$113.09
24-Stunden-Volumen:
736.99K
Relative Volume:
0.75
Marktkapitalisierung:
$2.60B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-37.49
EPS:
-3.11
Netto-Cashflow:
$-59.99M
1W Leistung:
+20.42%
1M Leistung:
+26.55%
6M Leistung:
+38.87%
1J Leistung:
+960.68%
1-Tages-Spanne:
$110.74
$117.35
1-Wochen-Bereich:
$101.06
$117.35
52-Wochen-Spanne:
$13.90
$117.35
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Vergleichen Sie WGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
116.73 | 2.60B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
429.31 | 159.25B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.85 | 132.37B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
437.86 | 32.95B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
107.73 | 28.58B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.52 | 24.90B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
GeneDx: Strengthening Leadership In Genomic Diagnostics (NASDAQ:WGS) - Seeking Alpha
GeneDx Holdings Corp. (WGS): Among the Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
10 Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - MSN
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results? - MSN
(WGS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - MSN
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand - Insider Monkey
GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition - Yahoo
GeneDx to acquire AI genomics firm Fabric Genomics By Investing.com - Investing.com South Africa
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million - Benzinga
GeneDx to Acquire Fabric Genomics for Up to $51 Million - marketscreener.com
GeneDx to acquire Fabric Genomics in a deal worth up to $51M - MSN
GeneDx Holdings Acquires Fabric Genomics for $33 Million - TipRanks
GeneDx to acquire AI genomics firm Fabric Genomics - Investing.com Australia
GeneDx stock in focus on Fabric Genomics buyout (WGS:NASDAQ) - Seeking Alpha
Genedx To Acquire Fabric Genomics - marketscreener.com
Major AI Genomics Deal: GeneDx Acquires Fabric to Transform Global Genetic Testing - Stock Titan
GeneDx (WGS) to Acquire Fabric Genomics in $51M Deal - GuruFocus
Is GeneDx Holdings Corp. (NASDAQ:WGS) Trading At A 31% Discount? - simplywall.st
GeneDx holdings CEO Katherine Stueland sells $4.18 million in stock By Investing.com - Investing.com India
GeneDx CFO Kevin Feeley sells $1.43 million in stock By Investing.com - Investing.com South Africa
GeneDx holdings CEO Katherine Stueland sells $4.18 million in stock - Investing.com Australia
GeneDx CFO Kevin Feeley sells $1.43 million in stock - Investing.com
GeneDx Holdings Corp. Executives Sell Shares - TradingView
GeneDx Q1 2025 Earnings Coming: Key Financial Results Set for April 30 - Stock Titan
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025 - Yahoo Finance
Why GeneDx Holdings Shares Are Under Pressure - TipRanks
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - Yahoo Finance
Prudential Financial Inc. Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Achieves 40% Diagnostic Success Rate in Rare Immune Disease Testing - Stock Titan
GeneDx CEO Stueland sells $4.45 million in stock - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock By Investing.com - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock - Investing.com
GeneDx Holdings Corp. Executives Sell Shares to Cover Tax Obligations - TradingView
GeneDx CEO Stueland sells $4.45 million in stock By Investing.com - Investing.com UK
Victory Capital Management Inc. Acquires Shares of 2,720 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
7 Up-and-Coming Stocks to Buy in 2025 - US News Money
How To Trade (WGS) - news.stocktradersdaily.com
3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2% - simplywall.st
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $96,416.32 in Stock - MarketBeat
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -March 20, 2025 at 04:52 pm EDT - Marketscreener.com
GeneDx Strengthens Team: 10 New Hires Receive Strategic Stock Awards Worth 46,340 RSUs - Stock Titan
Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba - Yahoo Finance
12 High Growth Low Debt Stocks to Invest in Now - Insider Monkey
Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)? - Yahoo Finance
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies - Yahoo Finance
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 09 '25 |
Option Exercise |
32.67 |
1,246 |
40,707 |
17,242 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 09 '25 |
Sale |
92.18 |
15,516 |
1,430,334 |
1,726 |
| Stueland Katherine | Chief Executive Officer |
Apr 09 '25 |
Sale |
89.62 |
46,594 |
4,175,817 |
1,720 |
4.51%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):